Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells
Author:
Funder
National Natural Science Foundation of China
NSFC
National Key Research and Development Program
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference50 articles.
1. Immunological landscape and immunotherapy of hepatocellular carcinoma;Prieto;Nat Rev Gastroenterol Hepatol,2015
2. MEF2: a central regulator of diverse developmental programs;Potthoff;Development,2007
3. MEF2 transcription factors: developmental regulators and emerging cancer genes;Pon;Oncotarget,2016
4. Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2–M transition genes;Ma;Cancer Res,2014
5. MEF2D transduces microenvironment stimuli to ZEB1 to promote epithelial-mesenchymal transition and metastasis in colorectal cancer;Su;Cancer Res,2016
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. DDX3X interacts with SIRT7 to promote PD-L1 expression to facilitate PDAC progression;Oncogenesis;2024-02-05
2. Interventing mitochondrial PD-L1 suppressed IFN-γ-induced cancer stemness in hepatocellular carcinoma by sensitizing sorafenib-induced ferroptosis;Free Radical Biology and Medicine;2024-02
3. Inhibition of SIRT7 promotes STAT1 activation and STAT1-dependent signaling in hepatocellular carcinoma;Cellular Signalling;2024-02
4. Protein lysine acetyltransferase CBP/p300: A promising target for small molecules in cancer treatment;Biomedicine & Pharmacotherapy;2024-02
5. SIRT7 promotes Hippo/YAP activation and cancer cell proliferation in hepatocellular carcinoma via suppressing MST1;Cancer Science;2024-01-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3